Wagner Andreas P. 4
4 · Alignment Healthcare, Inc. · Filed Mar 19, 2026
Research Summary
AI-generated summary of this filing
Alignment Healthcare (ALHC) CHRO Andreas Wagner Sells Shares
What Happened Andreas P. Wagner, Chief Human Resources Officer of Alignment Healthcare (ALHC), reported two open‑market sales to cover tax withholding tied to RSU vesting. On 2026-03-18 he sold 12,000 shares at a weighted‑average price of $17.84 for proceeds of $214,080, and on 2026-03-19 he sold 11,602 shares at a weighted‑average price of $18.22 for proceeds of $211,397 — total proceeds ≈ $425,477. These were sales (not purchases) and, per the filing, represent tax‑withholding dispositions rather than discretionary stock‑selling for investment reasons.
Key Details
- Transaction dates and reported weighted‑average prices:
- 2026-03-18: 12,000 shares sold @ $17.84 (total $214,080). Price range reported: $17.40–$18.24 (F2).
- 2026-03-19: 11,602 shares sold @ $18.22 (total $211,397). Price range reported: $18.18–$18.30 (F4).
- Total shares sold: 23,602; total proceeds ≈ $425,477.
- Purpose/footnotes: F1 indicates these sales were to satisfy tax withholding on vested restricted stock units (not a discretionary trade). F3 shows a Rule 10b5-1 plan adoption date of 11/21/2025. F2/F4 note weighted‑average prices and provide per‑share ranges; full breakdown available on request.
- Shares owned after transaction: not specified in the excerpt of the filing provided.
- Filing timeliness: Form 4 filed 2026-03-19 for transactions through 2026-03-18 — appears timely under standard reporting rules (not marked late).
Context Sales to cover tax withholding after RSU vesting are common and generally do not indicate a change in the insider’s view of the company. The presence of a 10b5‑1 plan and the F1 tax‑withholding note further suggest these were pre‑planned or mandatory dispositions rather than opportunistic market trades. For full holdings, price-by-price breakdowns, or other Form 4 details, consult the SEC filing (Accession: 0001628280-26-019906).
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-03-18$17.84/sh−12,000$214,080→ 160,230 total - Sale
Common Stock
[F3][F4]2026-03-19$18.22/sh−11,602$211,397→ 148,628 total
Footnotes (4)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
- [F2]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
- [F3]Date of Rule 10b5-1 plan adoption: 11/21/2025
- [F4]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.18 to $18.30. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.